mhurhangee/ep-ind-claims huggingface dataset:
An electric vehicle with front access, comprising: • a chassis, containing at least one front seat, provided with a front door for accessing said at least one front seat through a front of the vehicle; • front wheels and rear wheels; • at least one electric motor operating said rear wheels and/or front wheels and connected to a set of electric batteries fixed to the chassis; wherein said chassis further comprises: • a front portion, supporting the front wheels, said front door, and at least one side door for accessing the inside of the chassis through a side of the vehicle, and • a rear portion, supporting the rear wheels; • wherein said front portion and rear portion of the chassis are partially overlapped and are telescopically movable between a retracted position, to make it easier to park the vehicle, and an extended position increasing the separation between the front wheels and rear wheels, to increase an inner space of the chassis behind said at least one front seat; and wherein • said at least one side door and the rear portion of the chassis are partially superimposed in the retracted position of the chassis, disabling the opening of the mentioned at least one side door, and are not superimposed in the extended position of the chassis, enabling the opening of the mentioned at least one side door, providing access to the interior space of the chassis behind said at least one front seat and also optionally to said at least one front seat. • a chassis, containing at least one front seat, provided with a front door for accessing said at least one front seat through a front of the vehicle; • front wheels and rear wheels; • at least one electric motor operating said rear wheels and/or front wheels and connected to a set of electric batteries fixed to the chassis; • a front portion, supporting the front wheels, said front door, and at least one side door for accessing the inside of the chassis through a side of the vehicle, and • a rear portion, supporting the rear wheels; • wherein said front portion and rear portion of the chassis are partially overlapped and are telescopically movable between a retracted position, to make it easier to park the vehicle, and an extended position increasing the separation between the front wheels and rear wheels, to increase an inner space of the chassis behind said at least one front seat; and wherein • said at least one side door and the rear portion of the chassis are partially superimposed in the retracted position of the chassis, disabling the opening of the mentioned at least one side door, and are not superimposed in the extended position of the chassis, enabling the opening of the mentioned at least one side door, providing access to the interior space of the chassis behind said at least one front seat and also optionally to said at least one front seat.
A singular brake clip for use with a disc brake assembly and configured to be disposed between at least only one of a pair of guide rails of a brake pad of the disc brake assembly and an anchor bracket of the disc brake assembly, the brake clip comprising: a U-shaped section including a base leg with opposing upper and lower legs extending from the base leg, the base leg including a pair of retaining members that extend in a rearward direction from opposite edges of the base leg, each of the retaining members of the base leg includes a retention tab; an abutment leg extending from the lower leg of the U-shaped section, the abutment leg including a retention member provided on an outboard side thereof, the retention member of the abutment leg is configured to extend from the abutment leg in a rearward direction along a side surface of an anchor bracket; an extension leg extending from the abutment leg, wherein the abutment leg is in direct contact with at least a portion of both the anchor bracket and a brake pad of the disc brake assembly and the extension leg includes a lip portion which is in direct contact with at least a portion of the brake pad of the disc brake assembly when the brake clip is disposed therebetween; a first support leg that extends generally perpendicular from the upper leg; and a second support leg that includes at least a portion thereof that extends substantially perpendicular from the first support leg, wherein the second support leg includes a retention tab. a U-shaped section including a base leg with opposing upper and lower legs extending from the base leg, the base leg including a pair of retaining members that extend in a rearward direction from opposite edges of the base leg, each of the retaining members of the base leg includes a retention tab; an abutment leg extending from the lower leg of the U-shaped section, the abutment leg including a retention member provided on an outboard side thereof, the retention member of the abutment leg is configured to extend from the abutment leg in a rearward direction along a side surface of an anchor bracket; an extension leg extending from the abutment leg, wherein the abutment leg is in direct contact with at least a portion of both the anchor bracket and a brake pad of the disc brake assembly and the extension leg includes a lip portion which is in direct contact with at least a portion of the brake pad of the disc brake assembly when the brake clip is disposed therebetween; a first support leg that extends generally perpendicular from the upper leg; and a second support leg that includes at least a portion thereof that extends substantially perpendicular from the first support leg, wherein the second support leg includes a retention tab.
An extract of Cistanche tubulosa comprising a component for use in protecting eye cells from damage caused by oxidative stress through t-BHP, NaN 3, or blue light; wherein the component is selected from the group consisting of echinacoside, acteoside, isoacteoside, tubuloside A, and a combination thereof.
A method for loading at least one powder substance into recesses provided at a stent surface, the method comprising: - applying compression to said at least one powder substance to thereby form tablets insertable into said recesses, - loading at least one additional substance into said recesses, by partially filling said recesses with said at least one additional substance, and - inserting said tablets of said at least one substance into said recesses partially filled with said at least one additional substance, and wherein - said at least one substance includes an active principle with anti-inflammatory activity mixed with at least one or more second excipients selected from linear or branched saturated fatty acids comprising a number of carbon atoms from 4 to 18 or a mixture thereof, - said at least one additional substance includes an active principle with anti-proliferative activity mixed with at least one or more first excipients selected from linear or branched saturated fatty acids comprising a number of carbon atoms from 16 to 34 or a mixture thereof, and wherein said at least one or more first excipients or a mixture thereof has/have a melting temperature higher than the melting temperature of said at least one or more second excipients or a mixture thereof. - applying compression to said at least one powder substance to thereby form tablets insertable into said recesses, - loading at least one additional substance into said recesses, by partially filling said recesses with said at least one additional substance, and - inserting said tablets of said at least one substance into said recesses partially filled with said at least one additional substance, - said at least one substance includes an active principle with anti-inflammatory activity mixed with at least one or more second excipients selected from linear or branched saturated fatty acids comprising a number of carbon atoms from 4 to 18 or a mixture thereof, - said at least one additional substance includes an active principle with anti-proliferative activity mixed with at least one or more first excipients selected from linear or branched saturated fatty acids comprising a number of carbon atoms from 16 to 34 or a mixture thereof,
Rotary tablet press machine including: - a compression turret rotatable about a first axis with constant angular velocity including a die plate provided with a plurality of dies and a plurality of upper compression punches and a corresponding plurality of lower compression punches; - weighing devices for weighing said tablets; and - transferring organs for transferring tablets from said compression turret to said weighing devices - a control unit for driving and controlling said transferring organs; characterized in that said transferring organs include at least one transferring element (5, 6) provided with at least one seat (15, 16) for a respective tablet and rotatably driven around a second axis, controlled by said a control unit, in a respective cycle time (Tc) with angular velocity variable in such a way to be, in succession, rotated in a first phase with a first angular velocity (ω1) almost constant for drawing from said compression turret at least one tablet, rotated in a second phase with a variable second angular velocity for transferring said tablet from said compression turret to said weighing devices, stopped in a third phase for releasing said tablet to be weighed to said weighing devices and rotated in a fourth phase with a third angular velocity that is variable and increasing up to the first angular velocity (ω1) to be brought back at said compression turret and draw a successive tablet. - a compression turret rotatable about a first axis with constant angular velocity including a die plate provided with a plurality of dies and a plurality of upper compression punches and a corresponding plurality of lower compression punches; - weighing devices for weighing said tablets; and - transferring organs for transferring tablets from said compression turret to said weighing devices - a control unit for driving and controlling said transferring organs;
An arylamine compound of the following general formula having two triphenylamine structures within the molecule, the two triphenylamine structures being connected to each other by a single bond, or by a divalent group that does not contain a heteroatom, wherein R1 to R28 may be the same or different, and represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, cyano, trifluoromethyl, nitro, linear or branched alkyl of 1 to 6 carbon atoms that may have a substituent, cycloalkyl of 5 to 10 carbon atoms that may have a substituent, linear or branched alkenyl of 2 to 6 carbon atoms that may have a substituent, linear or branched alkyloxy of 1 to 6 carbon atoms that may have a substituent, cycloalkyloxy of 5 to 10 carbon atoms that may have a substituent, a substituted or unsubstituted aromatic hydrocarbon group, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted condensed polycyclic aromatic group, or substituted or unsubstituted aryloxy, which may bind to each other to form a ring, where at least one of R1 to R28 is a deuterium atom, or a substituent that contains a deuterium atom, and wherein A1 represents the divalent group of the following structural formulae to, or a single bond, wherein R29 to R32 may be the same or different, and represent a hydrogen atom or a deuterium atom, wherein R33 to R42 may be the same or different, and represent a hydrogen atom or a deuterium atom, wherein R43 to R50 may be the same or different, and represent a hydrogen atom or a deuterium atom, [Chemical Formula 5] -CH 2 - wherein R51 to R55 may be the same or different, and represent a hydrogen atom or a deuterium atom.
Line lamp having an elongate bulb, in particular a glass bulb, at least one base (6, 8) being provided for making electrical contact and for holding the line lamp, characterized in that at least one light-emitting diode is arranged in the bulb as an illuminant and at least one heat sink constructed as a sheet metal (38, 40), the at least one light-emitting diode being arranged on a printed circuit board accommodated in the bulb and the heat sink being designed in such a way as to serve to hold the printed circuit board, two metal sheets (38, 40) being provided which are each arranged at an end section (18, 20) of the printed circuit board.
A testing method for verifying keys, said method using a dataset of integers, the dataset being previously split into a plurality of subsets of the integers, each subset of the plurality of subsets of integers having a product data structure for a product of the integers in the subset, and each ordered pair of subsets in the dataset having a remainder data structure for factors of the integers in the subsets of the ordered pair; the method comprising the steps of: creating a subset including one or more integers to be added to the dataset of integers; generating a product data structure for the created subset, the product data structure based on computing a product of the one or more integers in the created subset; identifying distinct ordered pairs of subsets, each distinct ordered pair of subsets in the distinct ordered pairs of subsets comprising a subset from the dataset and the created subset; for each of the identified distinct ordered pairs of subsets, using the product data structure of the subsets to generate a remainder data structure for obtaining common factors of the integers in the subsets; determining whether the common factors in the remainder data structure for each of the identified distinct ordered pairs of subsets satisfy a threshold; and based on determining that the common factors in the remainder data structure satisfy the threshold, validating that the one or more integers in the created subset do not have common factors with any other integer in the dataset, wherein the integers are integer public keys for encryption or decryption, each of the integer public keys associated with a private key, and wherein the dataset of integers is a public key testing dataset for a system. creating a subset including one or more integers to be added to the dataset of integers; generating a product data structure for the created subset, the product data structure based on computing a product of the one or more integers in the created subset; identifying distinct ordered pairs of subsets, each distinct ordered pair of subsets in the distinct ordered pairs of subsets comprising a subset from the dataset and the created subset; for each of the identified distinct ordered pairs of subsets, using the product data structure of the subsets to generate a remainder data structure for obtaining common factors of the integers in the subsets; determining whether the common factors in the remainder data structure for each of the identified distinct ordered pairs of subsets satisfy a threshold; and based on determining that the common factors in the remainder data structure satisfy the threshold, validating that the one or more integers in the created subset do not have common factors with any other integer in the dataset, wherein the integers are integer public keys for encryption or decryption, each of the integer public keys associated with a private key, and wherein the dataset of integers is a public key testing dataset for a system.
A cloud system data management method, wherein the method comprises: creating, by a cloud system data management apparatus, a first virtual machine for a user and allocating a virtual data volume to the first virtual machine, wherein the first virtual machine has a home identifier, and the home identifier of the first virtual machine is used to identify the user to which the first virtual machine belongs; setting, by the cloud system data management apparatus, an identifier of the virtual data volume as an identifier corresponding to the home identifier of the first virtual machine; when the virtual data volume needs to be mounted to a second virtual machine, determining, by the cloud system data management apparatus, whether a home identifier of the second virtual machine corresponds to the identifier of the virtual data volume; and if the home identifier of the second virtual machine corresponds to the identifier of the virtual data volume, allowing, by the cloud system data management apparatus, the virtual data volume to be mounted to the second virtual machine; or if the home identifier of the second virtual machine does not correspond to the identifier of the virtual data volume, forbidding, by the cloud system data management apparatus, the virtual data volume to be mounted to the second virtual machine. creating, by a cloud system data management apparatus, a first virtual machine for a user and allocating a virtual data volume to the first virtual machine, wherein the first virtual machine has a home identifier, and the home identifier of the first virtual machine is used to identify the user to which the first virtual machine belongs; setting, by the cloud system data management apparatus, an identifier of the virtual data volume as an identifier corresponding to the home identifier of the first virtual machine; when the virtual data volume needs to be mounted to a second virtual machine, determining, by the cloud system data management apparatus, whether a home identifier of the second virtual machine corresponds to the identifier of the virtual data volume; and if the home identifier of the second virtual machine corresponds to the identifier of the virtual data volume, allowing, by the cloud system data management apparatus, the virtual data volume to be mounted to the second virtual machine; or if the home identifier of the second virtual machine does not correspond to the identifier of the virtual data volume, forbidding, by the cloud system data management apparatus, the virtual data volume to be mounted to the second virtual machine.
An instrument for ablating tissue, comprising: an electrode including a thermally-conductive tubular member with a closed distal end, the tubular member defining an external, electrically conductive outer surface adapted to connect to an electrical energy source, the electrode having an insulation layer disposed on the external, electrically conductive outer surface and an exposed portion at the distal end; at least one temperature control mechanism to regulate temperature at the exposed portion of the electrically conductive outer surface; characterised by: a cardiac sensor disposed within the interior cavity of the electrode configured to measure pre-treatment and post-treatment cardiac signals for comparison purposes; the apparatus further comprising a microprocessor that is configured to: compare the pre-treatment and post-treatment cardiac signals to determine progress of tissue ablation; and terminate ablation based on the comparison of the pre-treatment and post-treatment cardiac signals. an electrode including a thermally-conductive tubular member with a closed distal end, the tubular member defining an external, electrically conductive outer surface adapted to connect to an electrical energy source, the electrode having an insulation layer disposed on the external, electrically conductive outer surface and an exposed portion at the distal end; at least one temperature control mechanism to regulate temperature at the exposed portion of the electrically conductive outer surface; characterised by: a cardiac sensor disposed within the interior cavity of the electrode configured to measure pre-treatment and post-treatment cardiac signals for comparison purposes; the apparatus further comprising a microprocessor that is configured to: compare the pre-treatment and post-treatment cardiac signals to determine progress of tissue ablation; and terminate ablation based on the comparison of the pre-treatment and post-treatment cardiac signals. a cardiac sensor disposed within the interior cavity of the electrode configured to measure pre-treatment and post-treatment cardiac signals for comparison purposes; the apparatus further comprising a microprocessor that is configured to: compare the pre-treatment and post-treatment cardiac signals to determine progress of tissue ablation; and terminate ablation based on the comparison of the pre-treatment and post-treatment cardiac signals. compare the pre-treatment and post-treatment cardiac signals to determine progress of tissue ablation; and terminate ablation based on the comparison of the pre-treatment and post-treatment cardiac signals.
A method for producing, in particular processing or loading, a circuit board element, comprising the steps of - providing a substantially full-area carrier (1, 11, 21, 31) having an adhering surface layer (6, 22, 35); - disposing and fixing on said adhering surface (6, 22, 35) of the carrier (1, 11, 21, 31) a starting material of the circuit board element (2, 3, 4, 5, 12, 23, 32, 33, 34) to be produced, in particular processed or loaded; - producing, in particular processing or loading, the circuit board element (2, 3, 4, 5, 12, 23, 32, 33, 34) fixed to the carrier (1, 11, 21, 31) in a position fixed on the carrier (1, 11, 21, 31); and - removing the produced, in particular processed or loaded, circuit board element (2, 3, 4, 5, 12, 23, 32, 33, 34) from the carrier (1, 11, 21, 31), characterized in that a circuit board element configured with a surface deviating from a flat surface is disposed on the carrier in a recess or depression having a profile in the surface of the carrier material complementary to the surface contour of the circuit board element. - providing a substantially full-area carrier (1, 11, 21, 31) having an adhering surface layer (6, 22, 35); - disposing and fixing on said adhering surface (6, 22, 35) of the carrier (1, 11, 21, 31) a starting material of the circuit board element (2, 3, 4, 5, 12, 23, 32, 33, 34) to be produced, in particular processed or loaded; - producing, in particular processing or loading, the circuit board element (2, 3, 4, 5, 12, 23, 32, 33, 34) fixed to the carrier (1, 11, 21, 31) in a position fixed on the carrier (1, 11, 21, 31); and - removing the produced, in particular processed or loaded, circuit board element (2, 3, 4, 5, 12, 23, 32, 33, 34) from the carrier (1, 11, 21, 31),
Apoaequorin for use in a method of therapy comprising preconditioning neurons to reduce neuronal cell death following ischemia in a subject susceptible to ischemic cell death, said apoaequorin provided in a therapeutically effective dosage to precondition neurons in the subject to reduce neuronal cell death and wherein said apoaequorin is administered orally in the form of a nutraceutical composition.